Lupus & antiphospholipid syndrome

Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial

Rheumatology (Oxford)Published Prospective cohort study

Authors' conclusion

Renal involvement, haematological involvement and hypocomplementaemia were negative predictors of LLDAS achievement and maintenance. LLDAS-3mo was a positive predictor for the long-term sustainment of LLDAS.

Study context

Population
Active SLE patients, followed up quarterly from 2014 to 2016
Participants
245 patients
Exposure
Low-risk vs intermediate-risk vs high-risk groups by prognostic stratification tool
  • Low-riskn = 36
  • Intermediate-riskn = 100
  • High-riskn = 108
Outcome
Achievement of LLDAS
Follow-up
2 years
Methodological detailsmultivariate analysis, prognostic stratification tool
  • Multivariate analysis
  • Prognostic stratification tool

Main finding

As reported in the abstract

Probability of achieving LLDAS

2-year probability of achieving lupus low disease activity state (LLDAS) (154/245)

62.9%

Observational data: associations, not effects.

Further findings

LLDAS-3mo as predictor for LLDAS-50

Risk ratio (95% CI)P value
LLDAS-3mo47.694 (13.776–165.127)P < 0.0001

Achieving LLDAS by risk group

Achieving LLDAS-50 by risk group

Achieving LLDAS-3mo by risk group · 3 months

Achieving LLDAS by risk group — Significant differences in LLDAS Kaplan-Meier estimates for the three risk groups
P < 0.0001

Predictors for LLDAS-3mo (multivariate logistic analysis) · 3 months

Negative predictors: aPL positivity, hypocomplementaemia, renal involvement and haematological involvement

Original publication

Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial. Rheumatology (Oxford). Published 27 July 2022. doi:10.1093/rheumatology/keac419

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.